Neglected Tropical Diseases Diagnosis Market Size & Share, By Disease (Dengue, Chikungunya), Diagnostic Method (Conventional, Molecular/Modern), Service Type, End Use, Regional Forecast, Industry Players, Growth Statistics Report 2024-2032

Market Outlook:

Neglected Tropical Diseases Diagnosis Market exceeded USD 6.64 Billion in 2023 and is likely to cross USD 9.95 Billion by end of the year 2032, observing around 4.6% CAGR between 2024 and 2032.

• Base Year Value (2023): USD 6.64 Billion
• CAGR (2024-2032): 4.6%
• Forecast Year Value (2032): USD 9.95 Billion
• Historical Data Period: 2019-2023
• Largest Region: Asia Pacific
• Forecast Period: 2024-2032

Market Dynamics:

Growth Drivers & Opportunity:

The Neglected Tropical Diseases Diagnosis Market is expected to experience significant growth due to increasing government initiatives and funding for disease control programs. This has led to heightened awareness and screening efforts for neglected tropical diseases, driving up the demand for diagnostic tools and technologies.

Another major growth driver for the market is the rising prevalence of neglected tropical diseases in developing countries. The increasing incidence of these diseases, coupled with the lack of access to proper healthcare infrastructure, has created a strong need for accurate and timely diagnosis, driving the growth of the market.

Technological advancements and innovations in diagnostic tools and techniques are also propelling the growth of the Neglected Tropical Diseases Diagnosis Market. The development of rapid diagnostic tests, molecular diagnostic tools, and point-of-care devices has improved the accuracy and efficiency of disease diagnosis, leading to increased adoption and market growth.

Report Scope

Report Coverage	Details
Segments Covered	Disease, Diagnostic Method, Service Type, End-Use
Regions Covered	• North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA)
Company Profiled	F. Hoffmann-La Roche, Abbott, Thermo Fisher Scientific, ZeptoMetrix, InBios International,, Genome Diagnostics Pvt.., Omega Diagnostics Group PLC, Coris BioConcept, DiaSys Diagnostic Systems, Oscar Medicare Pvt.

Industry Restraints:

Despite the promising growth prospects, the Neglected Tropical Diseases Diagnosis Market faces challenges such as lack of awareness and education about these diseases among healthcare professionals and patients. This can hinder the timely diagnosis and treatment of neglected tropical diseases, impacting the market growth.

Moreover, the high cost of diagnostic tests and limited access to healthcare facilities in remote and underserved regions present major restraints for the market. The affordability and accessibility of diagnostic tools remain key barriers for the diagnosis and management of neglected tropical diseases, hindering the market growth potential.

Regional Forecast:

North America:

The Neglected Tropical Diseases Diagnosis market size in North America, particularly in the United States and Canada, is expected to witness steady growth due to the increasing awareness about these diseases among healthcare professionals and patients. The presence of well-established healthcare infrastructure and government initiatives to control neglected tropical diseases are driving the market growth in this region.

Asia Pacific:

In Asia Pacific, countries such as China, Japan, and South Korea are experiencing rapid growth in the Neglected Tropical Diseases Diagnosis Market. Factors such as high prevalence of neglected tropical diseases, increasing investments in healthcare infrastructure, and rising awareness about these diseases are contributing to the market growth in this region.

Europe:

Europe, including the United Kingdom, Germany, and France, is also witnessing significant growth in the Neglected Tropical Diseases Diagnosis Market. The presence of advanced healthcare facilities, favorable government policies, and increasing collaborations between regional and international healthcare organizations are propelling the market growth in Europe.

Segmentation Analysis:

In terms of segmentation, the global Neglected Tropical Diseases Diagnosis market is analyzed on the basis of Disease, Diagnostic Method, Service Type, End-Use.

Neglected Tropical Diseases Diagnosis Market

Dengue:

The Neglected Tropical Diseases Diagnosis Market for dengue is expected to witness significant growth due to the increasing prevalence of the disease in tropical and subtropical regions. The conventional diagnostic methods such as rapid diagnostic tests and serological tests are widely used for diagnosing dengue. However, the market for molecular/modern diagnostic methods like PCR and ELISA is also growing rapidly as they offer higher accuracy and sensitivity in detecting dengue virus.

Chikungunya:

Chikungunya is another neglected tropical disease that is causing a burden on healthcare systems, particularly in developing countries. The conventional diagnostic methods for chikungunya include rapid diagnostic tests and serological tests, which are widely used due to their affordability and accessibility. However, the market for molecular/modern diagnostic methods like RT-PCR is gaining traction as they offer quicker and more accurate results in detecting the chikungunya virus.

Diagnostic Method:

The Neglected Tropical Diseases Diagnosis Market is segmented based on diagnostic methods, including conventional and molecular/modern methods. While conventional diagnostic methods are more widely used due to their affordability and accessibility, the market for molecular/modern diagnostic methods is growing rapidly due to their higher accuracy and sensitivity in detecting neglected tropical diseases like dengue and chikungunya.

Service Type:

The Neglected Tropical Diseases Diagnosis Market also includes different service types such as testing services and consultancy services. Testing services, which include diagnostic testing for neglected tropical diseases, are expected to dominate the market due to the increasing demand for accurate and timely diagnosis. Consultancy services, on the other hand, are aimed at providing expert advice and guidance on managing and preventing neglected tropical diseases.

End Use:

The Neglected Tropical Diseases Diagnosis Market caters to various end users, including hospitals, diagnostic laboratories, research institutes, and others. Hospitals are expected to be the largest end user of diagnostic services for neglected tropical diseases, as they are the primary healthcare providers for patients suffering from these diseases. Diagnostic laboratories and research institutes are also significant end users, as they are involved in conducting diagnostic tests and research on neglected tropical diseases.

Competitive Landscape:

Competitive landscape in the Neglected Tropical Diseases Diagnosis Market: The Neglected Tropical Diseases Diagnosis Market is highly competitive with numerous key players striving to gain a significant market share. These companies are focusing on research and development to introduce innovative diagnostic techniques for effective disease detection. Some of the top companies operating in this market include:

Top Market Players:

1. QIAGEN

2. Thermo Fisher Scientific

3. bioMérieux

4. Siemens Healthineers

5. BD

6. Roche

7. Beckman Coulter

8. Bio-Rad Laboratories

9. Cepheid

10. Meridian Bioscience.